The global Mumps Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Mumps Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mumps Drug.

Report Scope

The Mumps Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mumps Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mumps Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Mumps Drug Market Report

Report Metric	Details
Report Name	Mumps Drug Market
CAGR	5%
Segment by Type	RIT 4385 Schwarz Wistar RA 27/3 Others
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Beijing Minhai Biotechnology Co., Ltd, Beijing Tiantan Biological Products Co., Ltd., China National Pharmaceutical Group Corporation, GlaxoSmithKline Plc, Organic Vaccines, Prometheon Pharma, LLC, Sinovac Biotech Ltd., Zydus Cadila Healthcare Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mumps Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mumps Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Mumps Drug Market report?

Ans: The main players in the Mumps Drug Market are Beijing Minhai Biotechnology Co., Ltd, Beijing Tiantan Biological Products Co., Ltd., China National Pharmaceutical Group Corporation, GlaxoSmithKline Plc, Organic Vaccines, Prometheon Pharma, LLC, Sinovac Biotech Ltd., Zydus Cadila Healthcare Limited

What are the Application segmentation covered in the Mumps Drug Market report?

Ans: The Applications covered in the Mumps Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Mumps Drug Market report?

Ans: The Types covered in the Mumps Drug Market report are RIT 4385, Schwarz, Wistar RA 27/3, Others

1 Mumps Drug Market Overview

1.1 Product Overview and Scope of Mumps Drug

1.2 Mumps Drug Segment by Type

1.2.1 Global Mumps Drug Market Value Comparison by Type (2024-2030)

1.2.2 RIT 4385

1.2.3 Schwarz

1.2.4 Wistar RA 27/3

1.2.5 Others

1.3 Mumps Drug Segment by Application

1.3.1 Global Mumps Drug Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Mumps Drug Market Size Estimates and Forecasts

1.4.1 Global Mumps Drug Revenue 2019-2030

1.4.2 Global Mumps Drug Sales 2019-2030

1.4.3 Global Mumps Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Mumps Drug Market Competition by Manufacturers

2.1 Global Mumps Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Mumps Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Mumps Drug Average Price by Manufacturers (2019-2024)

2.4 Global Mumps Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Mumps Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Mumps Drug, Product Type & Application

2.7 Mumps Drug Market Competitive Situation and Trends

2.7.1 Mumps Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Mumps Drug Players Market Share by Revenue

2.7.3 Global Mumps Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mumps Drug Retrospective Market Scenario by Region

3.1 Global Mumps Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Mumps Drug Global Mumps Drug Sales by Region: 2019-2030

3.2.1 Global Mumps Drug Sales by Region: 2019-2024

3.2.2 Global Mumps Drug Sales by Region: 2025-2030

3.3 Global Mumps Drug Global Mumps Drug Revenue by Region: 2019-2030

3.3.1 Global Mumps Drug Revenue by Region: 2019-2024

3.3.2 Global Mumps Drug Revenue by Region: 2025-2030

3.4 North America Mumps Drug Market Facts & Figures by Country

3.4.1 North America Mumps Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Mumps Drug Sales by Country (2019-2030)

3.4.3 North America Mumps Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Mumps Drug Market Facts & Figures by Country

3.5.1 Europe Mumps Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Mumps Drug Sales by Country (2019-2030)

3.5.3 Europe Mumps Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Mumps Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Mumps Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Mumps Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Mumps Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Mumps Drug Market Facts & Figures by Country

3.7.1 Latin America Mumps Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Mumps Drug Sales by Country (2019-2030)

3.7.3 Latin America Mumps Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Mumps Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Mumps Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Mumps Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Mumps Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Mumps Drug Sales by Type (2019-2030)

4.1.1 Global Mumps Drug Sales by Type (2019-2024)

4.1.2 Global Mumps Drug Sales by Type (2025-2030)

4.1.3 Global Mumps Drug Sales Market Share by Type (2019-2030)

4.2 Global Mumps Drug Revenue by Type (2019-2030)

4.2.1 Global Mumps Drug Revenue by Type (2019-2024)

4.2.2 Global Mumps Drug Revenue by Type (2025-2030)

4.2.3 Global Mumps Drug Revenue Market Share by Type (2019-2030)

4.3 Global Mumps Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Mumps Drug Sales by Application (2019-2030)

5.1.1 Global Mumps Drug Sales by Application (2019-2024)

5.1.2 Global Mumps Drug Sales by Application (2025-2030)

5.1.3 Global Mumps Drug Sales Market Share by Application (2019-2030)

5.2 Global Mumps Drug Revenue by Application (2019-2030)

5.2.1 Global Mumps Drug Revenue by Application (2019-2024)

5.2.2 Global Mumps Drug Revenue by Application (2025-2030)

5.2.3 Global Mumps Drug Revenue Market Share by Application (2019-2030)

5.3 Global Mumps Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Beijing Minhai Biotechnology Co., Ltd

6.1.1 Beijing Minhai Biotechnology Co., Ltd Corporation Information

6.1.2 Beijing Minhai Biotechnology Co., Ltd Description and Business Overview

6.1.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolio

6.1.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates

6.2 Beijing Tiantan Biological Products Co., Ltd.

6.2.1 Beijing Tiantan Biological Products Co., Ltd. Corporation Information

6.2.2 Beijing Tiantan Biological Products Co., Ltd. Description and Business Overview

6.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolio

6.2.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments/Updates

6.3 China National Pharmaceutical Group Corporation

6.3.1 China National Pharmaceutical Group Corporation Corporation Information

6.3.2 China National Pharmaceutical Group Corporation Description and Business Overview

6.3.3 China National Pharmaceutical Group Corporation Mumps Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 China National Pharmaceutical Group Corporation Mumps Drug Product Portfolio

6.3.5 China National Pharmaceutical Group Corporation Recent Developments/Updates

6.4 GlaxoSmithKline Plc

6.4.1 GlaxoSmithKline Plc Corporation Information

6.4.2 GlaxoSmithKline Plc Description and Business Overview

6.4.3 GlaxoSmithKline Plc Mumps Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline Plc Mumps Drug Product Portfolio

6.4.5 GlaxoSmithKline Plc Recent Developments/Updates

6.5 Organic Vaccines

6.5.1 Organic Vaccines Corporation Information

6.5.2 Organic Vaccines Description and Business Overview

6.5.3 Organic Vaccines Mumps Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Organic Vaccines Mumps Drug Product Portfolio

6.5.5 Organic Vaccines Recent Developments/Updates

6.6 Prometheon Pharma, LLC

6.6.1 Prometheon Pharma, LLC Corporation Information

6.6.2 Prometheon Pharma, LLC Description and Business Overview

6.6.3 Prometheon Pharma, LLC Mumps Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Prometheon Pharma, LLC Mumps Drug Product Portfolio

6.6.5 Prometheon Pharma, LLC Recent Developments/Updates

6.7 Sinovac Biotech Ltd.

6.6.1 Sinovac Biotech Ltd. Corporation Information

6.6.2 Sinovac Biotech Ltd. Description and Business Overview

6.6.3 Sinovac Biotech Ltd. Mumps Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sinovac Biotech Ltd. Mumps Drug Product Portfolio

6.7.5 Sinovac Biotech Ltd. Recent Developments/Updates

6.8 Zydus Cadila Healthcare Limited

6.8.1 Zydus Cadila Healthcare Limited Corporation Information

6.8.2 Zydus Cadila Healthcare Limited Description and Business Overview

6.8.3 Zydus Cadila Healthcare Limited Mumps Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Zydus Cadila Healthcare Limited Mumps Drug Product Portfolio

6.8.5 Zydus Cadila Healthcare Limited Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Mumps Drug Industry Chain Analysis

7.2 Mumps Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Mumps Drug Production Mode & Process

7.4 Mumps Drug Sales and Marketing

7.4.1 Mumps Drug Sales Channels

7.4.2 Mumps Drug Distributors

7.5 Mumps Drug Customers

8 Mumps Drug Market Dynamics

8.1 Mumps Drug Industry Trends

8.2 Mumps Drug Market Drivers

8.3 Mumps Drug Market Challenges

8.4 Mumps Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Beijing Minhai Biotechnology Co Ltd

China National Pharmaceutical Group Corporation

GlaxoSmithKline PLC

Organic Vaccines

Prometheon Pharma LLC

Sinovac Biotech Ltd.

Zydus Cadila Healthcare Limited

Beijing Tiantan Biological Products Co., Ltd.

List of Tables

Table 1. Global Mumps Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Mumps Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Mumps Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Mumps Drug Sales (K Pcs) of Key Manufacturers (2019-2024)

Table 5. Global Mumps Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Mumps Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Mumps Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Mumps Drug Average Price (USD/Pcs) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Mumps Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Mumps Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Mumps Drug, Product Type & Application

Table 12. Global Key Manufacturers of Mumps Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Mumps Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mumps Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Mumps Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Mumps Drug Sales by Region (2019-2024) & (K Pcs)

Table 18. Global Mumps Drug Sales Market Share by Region (2019-2024)

Table 19. Global Mumps Drug Sales by Region (2025-2030) & (K Pcs)

Table 20. Global Mumps Drug Sales Market Share by Region (2025-2030)

Table 21. Global Mumps Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Mumps Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Mumps Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Mumps Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Mumps Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Mumps Drug Sales by Country (2019-2024) & (K Pcs)

Table 27. North America Mumps Drug Sales by Country (2025-2030) & (K Pcs)

Table 28. North America Mumps Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Mumps Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Mumps Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Mumps Drug Sales by Country (2019-2024) & (K Pcs)

Table 32. Europe Mumps Drug Sales by Country (2025-2030) & (K Pcs)

Table 33. Europe Mumps Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Mumps Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Mumps Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Mumps Drug Sales by Region (2019-2024) & (K Pcs)

Table 37. Asia Pacific Mumps Drug Sales by Region (2025-2030) & (K Pcs)

Table 38. Asia Pacific Mumps Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Mumps Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Mumps Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Mumps Drug Sales by Country (2019-2024) & (K Pcs)

Table 42. Latin America Mumps Drug Sales by Country (2025-2030) & (K Pcs)

Table 43. Latin America Mumps Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Mumps Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Mumps Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Mumps Drug Sales by Country (2019-2024) & (K Pcs)

Table 47. Middle East & Africa Mumps Drug Sales by Country (2025-2030) & (K Pcs)

Table 48. Middle East & Africa Mumps Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Mumps Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Mumps Drug Sales (K Pcs) by Type (2019-2024)

Table 51. Global Mumps Drug Sales (K Pcs) by Type (2025-2030)

Table 52. Global Mumps Drug Sales Market Share by Type (2019-2024)

Table 53. Global Mumps Drug Sales Market Share by Type (2025-2030)

Table 54. Global Mumps Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Mumps Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Mumps Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Mumps Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Mumps Drug Price (USD/Pcs) by Type (2019-2024)

Table 59. Global Mumps Drug Price (USD/Pcs) by Type (2025-2030)

Table 60. Global Mumps Drug Sales (K Pcs) by Application (2019-2024)

Table 61. Global Mumps Drug Sales (K Pcs) by Application (2025-2030)

Table 62. Global Mumps Drug Sales Market Share by Application (2019-2024)

Table 63. Global Mumps Drug Sales Market Share by Application (2025-2030)

Table 64. Global Mumps Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Mumps Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Mumps Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Mumps Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Mumps Drug Price (USD/Pcs) by Application (2019-2024)

Table 69. Global Mumps Drug Price (USD/Pcs) by Application (2025-2030)

Table 70. Beijing Minhai Biotechnology Co., Ltd Corporation Information

Table 71. Beijing Minhai Biotechnology Co., Ltd Description and Business Overview

Table 72. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 73. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product

Table 74. Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates

Table 75. Beijing Tiantan Biological Products Co., Ltd. Corporation Information

Table 76. Beijing Tiantan Biological Products Co., Ltd. Description and Business Overview

Table 77. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 78. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product

Table 79. Beijing Tiantan Biological Products Co., Ltd. Recent Developments/Updates

Table 80. China National Pharmaceutical Group Corporation Corporation Information

Table 81. China National Pharmaceutical Group Corporation Description and Business Overview

Table 82. China National Pharmaceutical Group Corporation Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 83. China National Pharmaceutical Group Corporation Mumps Drug Product

Table 84. China National Pharmaceutical Group Corporation Recent Developments/Updates

Table 85. GlaxoSmithKline Plc Corporation Information

Table 86. GlaxoSmithKline Plc Description and Business Overview

Table 87. GlaxoSmithKline Plc Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 88. GlaxoSmithKline Plc Mumps Drug Product

Table 89. GlaxoSmithKline Plc Recent Developments/Updates

Table 90. Organic Vaccines Corporation Information

Table 91. Organic Vaccines Description and Business Overview

Table 92. Organic Vaccines Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 93. Organic Vaccines Mumps Drug Product

Table 94. Organic Vaccines Recent Developments/Updates

Table 95. Prometheon Pharma, LLC Corporation Information

Table 96. Prometheon Pharma, LLC Description and Business Overview

Table 97. Prometheon Pharma, LLC Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 98. Prometheon Pharma, LLC Mumps Drug Product

Table 99. Prometheon Pharma, LLC Recent Developments/Updates

Table 100. Sinovac Biotech Ltd. Corporation Information

Table 101. Sinovac Biotech Ltd. Description and Business Overview

Table 102. Sinovac Biotech Ltd. Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 103. Sinovac Biotech Ltd. Mumps Drug Product

Table 104. Sinovac Biotech Ltd. Recent Developments/Updates

Table 105. Zydus Cadila Healthcare Limited Corporation Information

Table 106. Zydus Cadila Healthcare Limited Description and Business Overview

Table 107. Zydus Cadila Healthcare Limited Mumps Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 108. Zydus Cadila Healthcare Limited Mumps Drug Product

Table 109. Zydus Cadila Healthcare Limited Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Mumps Drug Distributors List

Table 113. Mumps Drug Customers List

Table 114. Mumps Drug Market Trends

Table 115. Mumps Drug Market Drivers

Table 116. Mumps Drug Market Challenges

Table 117. Mumps Drug Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Mumps Drug

Figure 2. Global Mumps Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Mumps Drug Market Share by Type in 2023 & 2030

Figure 4. RIT 4385 Product Picture

Figure 5. Schwarz Product Picture

Figure 6. Wistar RA 27/3 Product Picture

Figure 7. Others Product Picture

Figure 8. Global Mumps Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Mumps Drug Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Others

Figure 13. Global Mumps Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Mumps Drug Market Size (2019-2030) & (US$ Million)

Figure 15. Global Mumps Drug Sales (2019-2030) & (K Pcs)

Figure 16. Global Mumps Drug Average Price (USD/Pcs) & (2019-2030)

Figure 17. Mumps Drug Report Years Considered

Figure 18. Mumps Drug Sales Share by Manufacturers in 2023

Figure 19. Global Mumps Drug Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Mumps Drug Players: Market Share by Revenue in 2023

Figure 21. Mumps Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Mumps Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Mumps Drug Sales Market Share by Country (2019-2030)

Figure 24. North America Mumps Drug Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Mumps Drug Sales Market Share by Country (2019-2030)

Figure 28. Europe Mumps Drug Revenue Market Share by Country (2019-2030)

Figure 29. Germany Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Mumps Drug Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Mumps Drug Revenue Market Share by Region (2019-2030)

Figure 36. China Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Mumps Drug Sales Market Share by Country (2019-2030)

Figure 47. Latin America Mumps Drug Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Mumps Drug Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Mumps Drug Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Mumps Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Mumps Drug by Type (2019-2030)

Figure 57. Global Revenue Market Share of Mumps Drug by Type (2019-2030)

Figure 58. Global Mumps Drug Price (USD/Pcs) by Type (2019-2030)

Figure 59. Global Sales Market Share of Mumps Drug by Application (2019-2030)

Figure 60. Global Revenue Market Share of Mumps Drug by Application (2019-2030)

Figure 61. Global Mumps Drug Price (USD/Pcs) by Application (2019-2030)

Figure 62. Mumps Drug Value Chain

Figure 63. Mumps Drug Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions